Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Therapy and Diagnosis

Preliminary Clinical Results for 18F-FDGPET/MR Compared with PET/CT in Patients with Suspected Recurrent or Metastatic Differentiated Thyroid Cancer

Liang Shi, Shaohua Li, Xiaochen Yao, Rencong Liu, Binbin Pan, Xiaowei Tang and Feng Wang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1285;
Liang Shi
1Nanjing First Hospital Nanjing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaohua Li
1Nanjing First Hospital Nanjing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaochen Yao
1Nanjing First Hospital Nanjing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rencong Liu
1Nanjing First Hospital Nanjing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Binbin Pan
1Nanjing First Hospital Nanjing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaowei Tang
1Nanjing First Hospital Nanjing China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Wang
2Nanjing First Hospital Nanjing
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1285

Purpose: To compare the diagnostic performance of 18F-FDG-PET/MR and PET/CT in patients with elevated thyroglobulin levels or a clinical suspicion of recurrent or metastatic differentiated thyroid cancer (DTC).

Methods: This prospective study included 35 thyroidectomized and remnant-ablated DTC patients (mean age = 51 ± 15.7 years) with signs of tumor recurrence/metastases. The datasets (whole-body PET/CT, whole-body PET/MRI) were rated by two readers regarding lesion conspicuity and diagnostic confidence. The Sensitivity, specificity, positive (PPV) and negative predictive values (NPV) for lesions in the local residual and lymph nodes in the neck, lungs, bones and other distant sites were calculated. The standard of reference included pathology and/or follow-up > 6 months.

Results: A total of 111 metastatic lesions were present in 21/35 patients; 10 patients had local recurrences or lymph node metastases in the neck, 7 had both local and distant recurrent disease, 2 had bone metastases only, and 2 had pulmonary metastases only. Reader confidence for the two examinations was similar (ICC = 0.889) with an excellent Inter-reader agreement for lesions (weighted kappa = 0.834 for PET/MRI and 0.818 for PET/CT) . In the patient-per-patient analysis, sensitivity and specificity of both tests were similar (p > 0.05). In the lesion-per-lesion analysis, the sensitivity of PET/MR and PET/CT for bone metastases, pulmonary metastases, local recurrences or lymphnode metastases in the neck, and all lesions together was 0.920 and 0.718 (p = 0.016), 0.841 and 0.923 (p = 0.031), 0.878 and 0.829 (p = 0.453), and 0.891 and 0.809 (p = 0.039) respectively. The corresponding specificity was 0.943 and 0.991 (p = 0.016), 0.933 and 0.976 (p = 0.125), 0.991 and 0.979 (p = 0.625), 0.966 and 0.983 (p = 0.008) respectively.

Conclusions: Diagnostic performance on a patient-per-patient basis, reader confidence and inter-reader agreement were similar with PET/MR and PET/CT. PET/CT had a significantly higher sensitivity but similar specificity to PET/MR for pulmonary metastases, while 18F-FDG PET/MR may be of great value in identifying bone metastases. Keywords: Positron emission tomography computed tomography; Magnetic resonance imaging; Metastases; Differentiated thyroid carcinoma

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preliminary Clinical Results for 18F-FDGPET/MR Compared with PET/CT in Patients with Suspected Recurrent or Metastatic Differentiated Thyroid Cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Preliminary Clinical Results for 18F-FDGPET/MR Compared with PET/CT in Patients with Suspected Recurrent or Metastatic Differentiated Thyroid Cancer
Liang Shi, Shaohua Li, Xiaochen Yao, Rencong Liu, Binbin Pan, Xiaowei Tang, Feng Wang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1285;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preliminary Clinical Results for 18F-FDGPET/MR Compared with PET/CT in Patients with Suspected Recurrent or Metastatic Differentiated Thyroid Cancer
Liang Shi, Shaohua Li, Xiaochen Yao, Rencong Liu, Binbin Pan, Xiaowei Tang, Feng Wang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1285;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

  • Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
  • Surveillance Imaging of Laryngeal Cancer - Does FDG PET/CT Impact Survival?
  • Assessment of semi-quantitative evaluation using SUV applying 2 phase-imaging of IMP SPECT for diagnosis of choroidal melanoma.
Show more Oncology: Clinical Therapy and Diagnosis

Head and Neck (Poster Session)

  • Clinical value of 99mTc-deoxy-glucose derivative SPECT/CT in tumors
  • Assessment of semi-quantitative evaluation using SUV applying 2 phase-imaging of IMP SPECT for diagnosis of choroidal melanoma.
  • Simultaneous PET/MR reveals significant correlation between the intravoxel incoherent motion parameters and standardized uptake values in nasopharyngeal carcinoma patients
Show more Head and Neck (Poster Session)

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire